Phase I Evaluation of the Safety of PS 341 in the Treatment of Recurrent Gliomas
Phase of Trial: Phase I
Latest Information Update: 23 Jan 2013
At a glance
- Drugs Bortezomib (Primary) ; Antiepileptic drugs
- Indications Anaplastic astrocytoma; Glioblastoma; Glioma
- Focus Adverse reactions
- 23 Jan 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 10 Jul 2007 Status changed from recruiting to completed.
- 22 Aug 2005 New trial record.